Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Michal Mysliwiec

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Biological Markers

Physiology

Chemicals & Drugs

Anatomy

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
95
Malyszko, Jolanta
82
Malyszko, Jacek
64
Pawlak, Krystyna
44
Pawlak, Dariusz
44
Borawski, Jacek
34
Buczko, Wlodzimierz
27
Hryszko, Tomasz
23
Naumnik, Beata
20
Azzadin, Arsalan
18
Wolczynski, Slawomir
17
Brzósko, Szymon
16
Rydzewski, A
12
Brzosko, Szymon
10
Lebkowska, Urszula
7
Rydzewska-Rosolowska, Alicja

Sign-in to see all Coauthors

Publications

TOP 3
Borawski Jacek; Dubowski Miroslaw; Rydzewska-Rosolowska Alicja; Mysliwiec Michal
Intravenous and oral sulodexide versus coagulation activation markers in humans.
Malyszko J; Malyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
Malyszko J; Malyszko J S; Mysliwiec M
A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michal Mysliwiec (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Borawski Jacek; Dubowski Miroslaw; Rydzewska-Rosolowska Alicja; Mysliwiec Michal
Intravenous and oral sulodexide versus coagulation activation markers in humans.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(5):596-8.
2009: Malyszko J; Malyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
Transplantation proceedings 2009;41(8):3069-72.
2009: Malyszko J; Malyszko J S; Mysliwiec M
A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Transplantation proceedings 2009;41(8):3056-9.
2009: Malyszko Jolanta; Malyszko Jacek S; Mysliwiec Michal
Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients.
Clinical transplantation 2009;23(5):681-6.
2009: Pawlak Krystyna; Domaniewski Tomasz; Mysliwiec Michal; Pawlak Dariusz
Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
Thrombosis research 2009;124(4):452-7.
2009: Pawlak Krystyna; Brzosko Szymon; Mysliwiec Michal; Pawlak Dariusz
Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease.
Atherosclerosis 2009;204(2):561-6.
2009: Pawlak Krystyna; Domaniewski Tomasz; Mysliwiec Michal; Pawlak Dariusz
The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease.
Atherosclerosis 2009;204(1):309-14.
2009: Naumnik Beata; Pawlak Krystyna; Mysliwiec Michal
Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
Thrombosis research 2009;123(4):631-6.
2009: Gozdzikiewicz Joanna; Borawski Jacek; Mysliwiec Michal
Pleiotropic effects of heparin and heparinoids in peritoneal dialysis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(1):92-7.
2009: Malyszko J; Malyszko J S; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
Transplantation proceedings 2009;41(1):158-61.
2009: Malyszko J; Malyszko J S; Mysliwiec M
Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipients.
Transplantation proceedings 2009;41(1):150-3.
2009: Malyszko Jolanta; Malyszko Jacek S; Mysliwiec Michal
Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: potential role of prohepcidin, hepcidin, and inflammation.
Renal failure 2009;31(7):544-8.
2009: Sulkowski Stanislaw; Wincewicz Andrzej; Zalewski Bogdan; Famulski Waldemar; Lotowska Joanna Maria; Koda Mariusz; Sobaniec-Lotowska Maria Elzbieta; Mysliwiec Michal; Baltaziak Marek; Pawlak Krystyna; Sulkowska Mariola
Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer--evaluation of the prognostic significance of these agents.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(11):1439-45.
2009: Borawski J; Gozdzikiewicz J; Dubowski M; Pawlak K; Mysliwiec M
Tissue factor pathway inhibitor release and depletion by sulodexide in humans.
Advances in medical sciences 2009;54(1):32-6.
2009: Malyszko Jolanta; Malyszko Jacek S; Mysliwiec Michal
Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
Kidney & blood pressure research 2009;32(4):235-8.
2009: Mazerska M; Mysliwiec M
Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
Advances in medical sciences 2009;54(1):37-40.
2009: Furman-Kuklinska K; Naumnik B; Mysliwiec M
Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report.
Advances in medical sciences 2009;54(1):116-9.
2009: Gasowska Katarzyna; Naumnik Beata; Klejna Katarzyna; Mysliwiec Michal
The influence of unfractionated and low-molecular weight heparins on the properties of human umbilical vein endothelial cells (HUVEC).
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2009;47(1):17-23.
2009: Brzosko Szymon; Szkolka Tomasz; Mysliwiec Michal
Kidney disease is a negative predictor of 30-day survival after acute ischaemic stroke.
Nephron. Clinical practice 2009;112(2):c79-85.
2008: Malyszko Jolanta; Malyszko Jacek S; Pawlak Krystyna; Drozdowska-Rams Lena; Brzosko Szymon; Mysliwiec Michal
Hepcidin is linked to anemia and inflammation in peritoneal dialysis patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2008;28(4):418-21.
2008: Pawlak Krystyna; Mysliwiec Michal; Pawlak Dariusz
Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure.
Cytokine 2008;43(1):98-101.
2008: Malyszko J; Malyszko J S; Kozminski P; Pawlak K; Mysliwiec M
Adipokines, linking adipocytes and vascular function in hemodialyzed patients, may also be possibly related to CD146, a novel adhesion molecule.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008;14(3):338-45.
2008: Rydzewska-Rosolowska Alicja; Brzosko Szymon; Borawski Jacek; Mysliwiec Michal
Staphylococcal scalded skin syndrome in the course of lupus nephritis.
Nephrology (Carlton, Vic.) 2008;13(3):265-6.
2008: Stogowska-Nikiciuk Barbara; Malyszko Jolanta; Malyszko Jacek Stanislaw; Pawlak Krystyna; Mysliwiec Michal
[The influence of simvastatin on hsCRP and some paramneters of hemostasis in patients with ischemic heart disease]
Przegla¸d lekarski 2008;65(2):68-72.
2008: Malyszko J; Malyszko J S; Pawlak K; Mysliwiec M
Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Advances in medical sciences 2008;53(1):32-6.
2008: Pawlak Krystyna; Zolbach Krzysztof; Borawski Jacek; Mysliwiec Michal; Kovalchuk Oksana; Chyczewski Lech; Pawlak Dariusz
Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients.
Thrombosis research 2008;123(1):166-70.
2008: Pawlak Krystyna; Mysliwiec Michal; Pawlak Dariusz
The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
Thrombosis research 2008;122(3):328-35.
2008: Brzosko Szymon; Hryszko Tomasz; Malyszko Jolanta; Malyszko Jacek Stanislaw; Mazerska Maria; Mysliwiec Michal
Femoral localization and higher ultrafiltration rate but not concentration of heparin used for canal locking of hemodialysis catheter are negative predictors for its malfunction.
American journal of nephrology 2008;28(2):298-303.
2008: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
Thrombosis research 2008;121(6):787-91.
2008: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients.
Thrombosis research 2008;121(4):543-8.
2007: Naumnik B; Malyszko J; Chyczewski L; Kovalchuk O; Malyszko J; Mysliwiec M
Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
Transplantation proceedings 2007;39(9):2748-50.
2007: Lebkowska U; Malyszko J; Lebkowski W; Brzósko S; Kowalewski R; Lebkowski T; Janica J; Michalak P; Gacko M; Mysliwiec M; Walecki J
The predictive value of arterial renal blood flow parameters in renal graft survival.
Transplantation proceedings 2007;39(9):2727-9.
2007: Naumnik Beata; Pawlak Krystyna; Mysliwiec Michal
Different effect of unfractionated heparin and enoxaparin on circulating proangiogenic factors during hemodialysis: A cross-over study.
Cytokine 2007;40(2):98-104.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
LIGHT--a new member of the TNF superfamily in the plasma, dialysate and urine of uremic patients; the impact of residual diuresis and presence of viral hepatitis.
Clinical biochemistry 2007;40(16-17):1240-4.
2007: Pawlak Krystyna; Mysliwiec Michal; Pawlak Dariusz
Chronic viral hepatitis and iron affect the plasma levels of LIGHT--a new member of the TNF superfamily in uraemic haemodialyzed patients.
Cytokine 2007;39(3):201-6.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Association between tissue factor, its pathway inhibitor and oxidative stress in peritoneal dialysis patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(5):467-71.
2007: Malyszko Jolanta; Malyszko Jacek S; Kozminski Piotr; Pawlak Krystyna; Mysliwiec Michal
Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Nephrology (Carlton, Vic.) 2007;12(3):246-53.
2007: Naumnik Beata; Borawski Jacek; Pawlak Krystyna; Mysliwiec Michal
Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-beta 1 during haemodialysis: a cross-over study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1690-6.
2007: Borawski Jacek; Zbroch Edyta; Rydzewska-Rosolowska Alicja; Pawlak Krystyna; Mysliwiec Michal
Sulodexide for hemodialysis anticoagulation in heparin-induced thrombocytopenia type II.
Journal of nephrology 2007;20(3):370-2.
2007: Borawski Jacek; Dubowski Miroslaw; Pawlak Krystyna; Mysliwiec Michal
Sulodexide induces hepatocyte growth factor release in humans.
European journal of pharmacology 2007;558(1-3):167-71.
2007: Borawski Jacek; Wilczynska-Borawska Magdalena; Stokowska Wanda; Mysliwiec Michal
The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(2):457-64.
2007: Malyszko Jolanta; Malyszko Jacek S; Pawlak Krystyna; Mysliwiec Michal
Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations?
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2007;17(1):30-7.
2007: Gozdzikiewicz Joanna; Borawski Jacek; Mysliwiec Michal
Treatment of heparin-induced thrombocytopenia type II in hemodialysis patients: the search for a Holy Grail continues.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007;13(1):110-1.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
Clinical biochemistry 2007;40(1-2):81-5.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients.
Atherosclerosis 2007;190(1):199-204.
2007: Chabowska A; Sulkowska M; Wincewicz A; Chabowski A; Mysliwiec M; Pawlak K; Koda M; Kedra B; Sulkowski S
Serum erythropoietin and angiogenetic factors in human colorectal cancer.
Prague medical report 2007;108(4):348-57.
2007: Panasiuk B; Lesniewicz R; Spólczynska A; Mysliwiec M; de Die Smulders Ch; Sawicka A; Midro A T
Translocation form of Wolf-Hirschhorn syndrome --assessment of recurrence rate probability.
Advances in medical sciences 2007;52 Suppl 1():166-70.
2007: Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko J S; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S
Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
Kidney & blood pressure research 2007;30(6):408-15.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Erythropoietin therapy decreased tissue factor, its pathway inhibitor, and oxidative stress in peritoneal dialysis patients with diabetes.
Nephron. Clinical practice 2007;107(1):c20-5.
2007: Malyszko Jolanta; Malyszko Jacek S; Kozminski Piotr; Pawlak Krystyna; Wolczynski Slawomir; Mysliwiec Michal
Markers of bone metabolism in hemodialyses and hemodiafiltration.
Renal failure 2007;29(5):595-601.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
Thrombosis research 2007;120(6):797-803.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients.
American journal of nephrology 2007;27(3):221-5.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
Thrombosis research 2007;120(6):871-6.
2007: Malyszko Jolanta; Mysliwiec Michal
Hepcidin in anemia and inflammation in chronic kidney disease.
Kidney & blood pressure research 2007;30(1):15-30.
2007: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Thrombosis research 2007;119(4):475-80.
2006: Malyszko J; Malyszko J S; Pawlak K; Mysliwiec M
Possible relations between thyroid function, endothelium, and kidney and liver function in kidney allograft recipients.
Transplantation proceedings 2006;38(10):3509-13.
2006: Naumnik Beata; Borawski Jacek; Chyczewski Lech; Pawlak Krystyna; Mysliwiec Michal
Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(12):3450-7.
2006: Malyszko J; Malyszko J S; Pawlak K; Mysliwiec M
Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Transplantation proceedings 2006;38(9):2895-8.
2006: Malyszko Jolanta; Malyszko Jacek S; Pawlak Krystyna; Mysliwiec Michal
Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
American journal of hematology 2006;81(11):832-7.
2006: Gozdzikiewicz Joanna; Borawski Jacek; Naumnik Beata; Rydzewska-Rosolowska Alicja; Pawlak Krystyna; Mysliwiec Michal
TGF-beta1 and endothelial/tissue injury with high-dose intravenous iron therapy in renal failure: evidence or perception?
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(4):493-4.
2006: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
Cytokine 2006;35(5-6):258-62.
2006: Borawski Jacek; Mysliwiec Michal
[Relevance of some growth factors to cardiovascular disease in maintenance hemodialysis patients]
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2006;21(122):117-8; discussion 119.
2006: Pawlak Krystyna; Pawlak Dariusz; Brzosko Szymon; Mysliwiec Michal
Carotid atherosclerosis is associated with enhanced beta-chemokine levels in patients on continuous ambulatory peritoneal dialysis.
Atherosclerosis 2006;186(1):146-51.
2006: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients.
Medical science monitor : international medical journal of experimental and clinical research 2006;12(4):CR181-5.
2006: Borawski Jacek; Naumnik Beata; Rydzewska-Rosolowska Alicja; Mysliwiec Michal
Myeloperoxidase up-regulation during haemodialysis: is heparin the missing link?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(4):1128; author reply 1128-30.
2006: Malyszko Jacek S; Malyszko Jolanta; Hryszko Tomasz; Kozminski Piotr; Pawlak Krystyna; Mysliwiec Michal
Markers of endothelial damage in patients on hemodialysis and hemodiafiltration.
Journal of nephrology 2006;19(2):150-4.
2006: Malyszko J; Malyszko J S; Hryszko T; Mysliwiec M
Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients.
Transplantation proceedings 2006;38(1):105-7.
2006: Lebkowska U; Malyszko J; Brzósko S; Lebkowski W; Malyszko J S; Janica J; Kowalewski R; Gacko M; Mysliwiec M; Walecki J
Renal artery resistance index, thyroid hormones, and thyroid volume in the early kidney transplants recipients.
Transplantation proceedings 2006;38(1):62-5.
2006: Malyszko Jolanta; Malyszko Jacek; Wolczynski Slawomir; Mysliwiec Michal
Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(1):145-52.
2006: Borawski Jacek; Kovalchuk Oksana; Chlebinska Iwona; Naumnik Beata; Rydzewska-Rosolowska Alicja; Chyczewski Lech; Mysliwiec Michal
[SEN virus infection in maintenance hemodialysis patients]
Wiadomosci lekarskie (Warsaw, Poland : 1960) 2006;59(11-12):751-6.
2006: Malyszko J; Malyszko J S; Pawlak K; Wolczynski S; Mysliwiec M
Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Advances in medical sciences 2006;51():69-72.
2006: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients.
American journal of nephrology 2006;26(5):497-502.
2006: Malyszko Jolanta; Malyszko Jacek S; Kozminski Piotr; Mysliwiec Michal
Apelin and cardiac function in hemodialyzed patients: possible relations?
American journal of nephrology 2006;26(2):121-6.
2006: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
Thrombosis research 2006;117(5):517-22.
2005: Wilczynska-Borawska Magdalena; Borawski Jacek; Kovalchuk Oksana; Chyczewski Lech; Mysliwiec Michal; Stokowska Wanda
Unexpected effect of haemodialysis on salivary hepatocyte growth factor.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(12):2869-70.
2005: Malyszko Jolanta; Malyszko Jacek S; Hryszko Tomasz; Pawlak Krystyna; Mysliwiec Michal
Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
American journal of nephrology 2005;25(6):586-90.
2005: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease.
Clinical biochemistry 2005;38(8):700-5.
2005: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
Cytokine 2005;31(1):18-24.
2005: Malyszko J; Malyszko J S; Pawlak K; Konstantynowicz J; Wolczynski S; Kaczmarski M; Mysliwiec M
Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients.
Transplantation proceedings 2005;37(5):2151-3.
2005: Malyszko Jolanta; Malyszko Jacek S; Brzosko Szymon; Wolczynski Slawomir; Mysliwiec Michal
Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients.
American journal of nephrology 2005;25(3):203-10.
2005: Malyszko Jolanta; Malyszko Jacek S; Hryszko Tomasz; Brzosko Szymon; Lebkowska Urszula; Mysliwiec Michal
Renal transplant recipients with coronary artery disease exhibit impairment in fibrinolysis and structural changes in carotid arteries.
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(2):256-9.
2005: Lisowski P; Malyszko J; Hirnle T; Lisowska A; Jackowski R; Malyszko J S; Buzun L; Mysliwiec M
Thrombin activatable fibrinolysis inhibitor (TAFI) in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG).
Roczniki Akademii Medycznej w Bialymstoku (1995) 2005;50():166-72.
2005: Malyszko J; Malyszko J S; Mysliwiec M; Buczko W
Hemostasis in chronic renal failure.
Roczniki Akademii Medycznej w Bialymstoku (1995) 2005;50():126-31.
2005: Tankiewicz A; Pawlak D; Pawlak K; Szewc D; Mysliwiec M; Buczko W
Anthranilic acid-uraemic toxin damaged red cell's membrane.
International urology and nephrology 2005;37(3):621-7.
2005: Brzosko S; Lebkowska U; Malyszko J; Hryszko T; Krauze-Brzosko K; Mysliwiec M
Intima media thickness of common carotid arteries is associated with traditional risk factors and presence of ischaemic heart disease in hemodialysis patients.
Physiological research / Academia Scientiarum Bohemoslovaca 2005;54(5):497-504.
2005: Malyszko Jolanta; Malyszko Jacek S; Mysliwiec Michal
Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
Thrombosis research 2005;115(1-2):19-24.
2004: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease.
American journal of nephrology 2004;24(6):635-40.
2004: Malyszko Jolanta; Malyszko Jacek S; Hryszko Tomasz; Pawlak Krystyna; Mysliwiec Michal
Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients.
American journal of nephrology 2004;24(6):624-9.
2004: Borawski Jacek; Gozdzikiewicz Joanna; Abramowicz Pawel; Naumnik Beata; Mysliwiec Michal
Endothelial injury markers with high-dose intravenous iron therapy in renal failure.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(4):403-6.
2004: Malyszko Jolanta; Malyszko Jacek S; Brzosko Szymon; Wolczynski Slawomir; Mysliwiec Michal
Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients.
The Journal of clinical endocrinology and metabolism 2004;89(9):4620-7.
2004: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients.
Thrombosis and haemostasis 2004;92(3):646-53.
2004: Malyszko Jolanta; Malyszko Jacek S; Bondyra Zofia; Wolczynski Slawomir; Lebkowska Urszula; Mysliwiec Michal
Bone mineral density and bone metabolism are not related to leptin in hemodialyzed and peritoneally dialyzed uremic patients.
Medical science monitor : international medical journal of experimental and clinical research 2004;10 Suppl 3():115-9.
2004: Lisowski Piotr; Malyszko Jolanta; Lisowska Anna; Czech Bronislaw; Mysliwiec Michal; Jackowski Ryszard; Hirnle Tomasz
[Role of the hemostasis in unstable angina pectoris]
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2004;16(95):468-71.
2004: Lisowski Piotr; Malyszko Jolanta; Lisowska Anna; Czech Bronislaw; Mysliwiec Michal; Jackowski Ryszard; Hirnle Tomasz
[Role of the hemostatic system in pathogenesis of atherosclerosis as the main etiology of coronary ischemia] [corrected]
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2004;16(95):465-7.
2004: Lisowski Piotr; Malyszko Jolanta; Jackowski Ryszard; Mysliwiec Michal; Lisowska Anna; Lapinski Tomasz; Pawlak Krystyna; Hirnle Tomasz
[The role of thrombin activatable fibrinolysis inhibitors (TAFI) in coronary artery disease]
Polskie archiwum medycyny wewn?trznej 2004;111(3):385-9.
2004: Malyszko Jolanta; Malyszko Jacek S; Hryszko Tomasz; Mysliwiec Michal
Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
Thrombosis and haemostasis 2004;91(3):480-6.
2004: Lisowski Piotr; Malyszko Jolanta; Jackowsk Ryszard; Mysliwiec Michal; Lisowska Anna; Lapinski Tomasz; Pawlak Krystyna; Hirnle Tomasz
Effects of coronary artery by-pass grafting on haemostatic factors.
Kardiologia polska 2004;60(2):112-22.
2004: Pawlak Krystyna; Naumnik Beata; Brzósko Szymon; Pawlak Dariusz; Mysliwiec Michal
Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients.
American journal of nephrology 2004;24(1):154-61.
2004: Malyszko J S; Malyszko J; Skrzydlewska E; Pawlak K; Mysliwiec M
Protein Z and vitamin K in kidney disease.
Roczniki Akademii Medycznej w Bialymstoku (1995) 2004;49():197-200.
2004: Mysliwiec M; Borawski J; Naumnik B; Rydzewska-Rosolowska A
Endothelial dysfunction, atherosclerosis and thrombosis in uremia--possibilities of intervention.
Roczniki Akademii Medycznej w Bialymstoku (1995) 2004;49():151-6.
2004: Pawlak Krystyna; Pawlak Dariusz; Mysliwiec Michal
Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Nephron. Physiology 2004;96(4):p105-12.
2004: Hryszko Tomasz; Brzosko Szymon; Mazerska Maria; Malyszko Jolanta; Mysliwiec Michal
Risk factors of nontunneled noncuffed hemodialysis catheter malfunction. A prospective study.
Nephron. Clinical practice 2004;96(2):c43-7.
2004: Malyszko Jolanta; Malyszko Jacek S; Mysliwiec Michal
Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
Kidney & blood pressure research 2004;27(2):71-7.
2003: Malyszko J; Malyszko J S; Hryszko T; Mysliwiec M
Some aspects of hemostasis in kidney transplant recipients maintained on cyclosporine, azathioprine, and prednisone in comparison to patients treated with cyclosporine and prednisone.
Transplantation proceedings 2003;35(8):2940-2.
2003: Brzosko S; Hryszko T; Lebkowska U; Malyszko J; Malyszko J S; Mysliwiec M
Plasma tissue-type plasminogen activator, fibrinogen, and time on dialysis prior to transplantation are related to carotid intima media thickness in renal transplant recipients.
Transplantation proceedings 2003;35(8):2931-4.
2003: Borawski Jacek; Naumnik Beata; Mysliwiec Michal
Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: role of heparin.
Kidney international 2003;64(6):2229-37.
2003: Kazberuk Waldemar; Pawlak Krystyna; Mysliwiec Michal
[Hepatocyte growth factor (HGF) in stable and unstable coronary heart disease]
Polskie archiwum medycyny wewn?trznej 2003;110(5):1283-8.
2003: Malyszko Jolanta; Brzósko Szymon; Wolczynski Slawomir; Malyszko Jacek S; Mysliwiec M
[Bone metabolism in dialysis patient assessed by biochemical markers and densitometry]
Polskie archiwum medycyny wewn?trznej 2003;110(3):967-72.
2003: Malyszko J; Malyszko J S; Wolczynski S; Mysliwiec M
Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients.
Transplantation proceedings 2003;35(6):2227-9.
2003: Malyszko J; Malyszko J S; Hryszko T; Mysliwiec M
Thrombin-activatable fibrinolysis inhibitor in kidney transplant recipient with dyslipidemia.
Transplantation proceedings 2003;35(6):2219-21.
2003: Zbroch Edyta; Malyszko Jolanta; Mysliwiec Michal
[Unusual noninfectious complications of peritoneal dialysis]
Polskie archiwum medycyny wewn?trznej 2003;110(2):921-3.
2003: Borawski Jacek; Naumnik Beata; Mysliwiec Michal
Serum alpha1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients.
Renal failure 2003;25(4):589-93.
2003: Naumnik Beata; Borawski Jacek; Mysliwiec Michal
Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(7):1376-82.
2003: Malyszko J; Wolczynski S; Malyszko J S; Konstantynowicz J; Kaczmarski M; Mysliwiec M
Correlations of new markers of bone formation and resorption in kidney transplant recipients.
Transplantation proceedings 2003;35(4):1351-4.
2003: Malyszko Jolanta; Malyszko Jacek S; Hryszko Tomasz; Mysliwiec Michal
Influence of simvastatin on aspects of thrombogenesis in CAPD patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2003;23(3):260-6.
2003: Naumnik Beata; Borawski Jacek; Mysliwiec Michal
[Activin A-follistatin: new cytokines, new perspectives]
Polskie archiwum medycyny wewn?trznej 2003;109(4):431-5.
2003: Pawlak Krystyna; Borawski Jacek; Naumnik Beata; Mysliwiec Michal
Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients.
Thrombosis research 2003;109(5-6):247-51.
2003: Lebkowska Urszula; Malyszko Jacek S; Malyszko Jolanta; Dzieciol Janusz; Walecki Jerzy; Mysliwiec Michal
Thyroid function and incidentalomas in kidney transplant recipients.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(2):MT8-MT11.
2003: Malyszko Jolanta; Malyszko Jacek S; Mysliwiec Michal
Fluvastin therapy affects TAFI concentration in kidney transplant recipients.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(1):53-7.
2003: Pawlak Dariusz; Koda Mariusz; Wolczynski Sawomir; Mysliwiec Michal; Buczko Wlodzimierz
Mechanism of inhibitory effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency.
Advances in experimental medicine and biology 2003;527():375-80.
2002: Borawski Jacek; Pawlak Krystyna; Naumnik Beata; Mysliwiec Michal
Relations between oxidative stress, hepatocyte growth factor, and liver disease in hemodialysis patients.
Renal failure 2002;24(6):825-37.
2002: Borawski Jacek; Naumnik Beata; Mysliwiec Michal
Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2002;8(4):359-67.
2002: Malyszko J; Malyszko J S; Mysliwiec M
Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(7):615-21.
2002: Azzadin Arsalan; Malyszko Jolanta; Malyszko Jacek S; Tankiewicz Anna; Mysliwiec Michal; Buczko Wlodzimierz
Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
Polish journal of pharmacology 2002;54(5):469-73.
2002: Malyszko Jolanta; Suchowierska Ewa; Malyszko Jacek S; Mysliwiec Michal
A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2002;22(5):582-92.
2002: Borawski Jacek; Pawlak Krystyna; Mysliwiec Michal
Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
Nephron 2002;91(4):671-81.
2002: Naumnik Beata; Borawski Jacek; Pawlak Krystyna; Mysliwiec Michal
Effect of hemodialysis on plasma levels of vascular endothelial markers.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2002;8(3):245-50.
2002: Lebkowska Urszula; Malyszko J; Brzósko S; Walecki J; Mysliwiec M
Thyroid gland function in patients after renal transplantation.
Transplantation proceedings 2002;34(2):596-7.
2002: Malyszko Jolanta; Lebkowska U; Wolczynski S; Malyszko J S; Mysliwiec M
Parathyroid gland sonography in relation to markers of bone metabolism in kidney transplant recipients.
Transplantation proceedings 2002;34(2):593-5.
2002: Malyszko Jolanta; Wolczynski S; Malyszko J S; Mysliwiec M
Correlations between new markers of bone formation versus bone resorption in kidney transplant recipients.
Transplantation proceedings 2002;34(2):591-2.
2002: Malyszko Jolanta; Wolczynski S; Malyszko J S; Mysliwiec M
Aluminium and beta-2-microglobulin in kidney transplant recipients.
Transplantation proceedings 2002;34(2):580-2.
2002: Malyszko Jolanta; Wolczynski Slawomir; Zbroch Edyta; Brzósko Szymo; Malyszko Jacek; Mysliwiec Michal
Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients.
Nephron 2002;90(3):282-9.
2002: Brzósko Szymon; Hryszko Tomasz; Zak Janusz; Wysocka Jolanta; Mysliwiec Michal
Platelet glycoprotein Ib and reactivity of platelets in diabetic and non-diabetic hemodialysed patients.
Thrombosis and haemostasis 2002;87(2):344-5.
2002: Borawski Jacek; Mysliwiec Michal
Effects of recombinant erythropoietin therapy on circulating endothelial markers in hemodialysis patients.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2002;8(1):77-84.
2002: Borawski Jacek; Mysliwiec Michal
Hemoglobin level is an important determinant of acid-base status in hemodialysis patients.
Nephron 2002;90(1):111-3.
2002: Malyszko J; Malyszko J S; Hryszko T; Brzosko S; Mysliwiec M
Simvastatin and markers of endothelial function in patients undergoing continuous ambulatory peritoneal dialysis.
International journal of tissue reactions 2002;24(3):111-5.
2002: Brzósko Szymon; Hryszko Tomasz; Zak Janusz; Wysocka Jolanta; Malyszko Jolanta; Mysliwiec Michal
[Influence of hemodialysis on expression of glycoprotein lb platelets reactivity in patients with the end stage renal failure]
Przegla¸d lekarski 2002;59(10):823-5.
2002: Malyszko Jolanta; Suchowierska Ewa; Malyszko Jacek S; Mysliwiec Michal
Some aspects of hemostasis in CAPD patients treated with erythropoietin.
Kidney & blood pressure research 2002;25(4):240-4.
2002: Malyszko Jolanta; Malyszko Jacek S; Takada Akikazu; Mysliwiec Michal
Effects of immunosuppressive drugs on platelet aggregation in vitro.
Annals of transplantation : quarterly of the Polish Transplantation Society 2002;7(1):55-68.
2002: Malyszko Jolanta; Malyszko Jacek S; Brzósko Szymon; Pawlak Krystyna; Mysliwiec Michal
Effects of fluvastatin on homocysteine and serum lipids in kidney allograft recipients.
Annals of transplantation : quarterly of the Polish Transplantation Society 2002;7(1):52-4.
2002: Malyszko Jolanta; Malyszko Jacek S; Suchowierska Ewa; Pawlak Krystyna; Mysliwiec Michal
[Extrinsic coagulation pathway in peritoneally dialyzed patients treated with erythropoietin]
Przegla¸d lekarski 2002;59(3):139-41.
2002: Zbroch Edyta; Malyszko Jolanta; Mysliwiec Michal
[Disorders of bone metabolism after renal transplantation]
Przegla¸d lekarski 2002;59(1):43-5.
2001: Brzosko S; Mysliwiec M; Donati M B; Iacoviello L
Homocysteinemia in patients with type 1 diabetes in relation to renal function.
Diabetes care 2001;24(12):2158.
2001: Borawski J; Mysliwiec M
The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients.
Nephron 2001;89(4):381-3.
2001: Hryszko T; Malyszko J; Malyszko J S; Brzósko S; Mysliwiec M
Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor.
Thrombosis research 2001;104(4):233-8.
2001: Borawski J; Mysliwiec M
Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(4):296-9.
2001: Brzósko S; Lebkowska U; Malyszko J; Hryszko T; Pawlak K; Mysliwiec M
Correlation between carotid intima-media thickness and hematocrit and hemoglobin values in renal transplant recipients.
Clinical transplantation 2001;15(5):349-53.
2001: Malyszko J; Malyszko J S; Hryszko T; Mysliwiec M
Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients.
American journal of nephrology 2001;21(5):373-7.
2001: Hryszko T; Malyszko J; Malyszko J S; Brzosko S; Pawlak K; Mysliwiec M
A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(8):1692-6.
2001: Borawski J; Naumnik B; Pawlak K; Mysliwiec M
Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(7):1442-7.
2001: Borawski J; Naumnik B; Pawlak K; Mysliwiec M
Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(4):787-92.
2001: Malyszko J; Suchowierska E; Pawlak K; Malyszko J S; Mysliwiec M
[Platelet aggregation and P-selectin concentration in patients on peritoneal dialysis treated with erythropoietin]
Polskie archiwum medycyny wewn?trznej 2001;105(3):197-201.
2001: Malyszko J; Wolczynski S; Zbroch E; Brzósko S; Malyszko J; Mysliwiec M
Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzed and peritoneally dialyzed patients.
Nephron 2001;87(3):283-5.
2001: Brzósko S; Hryszko T; Malyszko J; Mysliwiec M
[Homocysteine--new risk factor for progression of atherosclerosis and its complications]
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2001;10(55):56-9.
2001: Pawlak D; Pawlak K; Malyszko J; Mysliwiec M; Buczko W
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
International urology and nephrology 2001;33(2):399-404.
2001: Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Mysliwiec M
[Nephrolithiasis in a HIV infected patient treated with indinavir]
Przegla¸d lekarski 2001;58(6):528-9.
2001: Hryszko T; Malyszko J; Brzósko S; Mysliwiec M
[TAFI--thrombin activated fibrinolysis inhibitor ]
Przegla¸d lekarski 2001;58(3):136-8.
2000: Borawski J; Pawlak K; Mysliwiec M
Comparison of different assays for von Willebrand factor in hemodialysis patients.
Haemostasis 2000;30(6):308-15.
2000: Malyszko J; Malyszko J S; Mysliwiec M
Effects of mycophenolate mofetil and mycophenolic acid on platelet aggregation in vitro.
Transplantation proceedings 2000;32(6):1347-9.
2000: Malyszko J S; Malyszko J; Mysliwiec M
Serum lipids and hemostasis in kidney allograft recipients treated with fluvastatin (Lescol) for 3 months.
Transplantation proceedings 2000;32(6):1344-6.
2000: Malyszko J; Zbroch E; Wolczynski S; Malyszko J S; Hryszko T; Mysliwiec M
Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy.
American journal of nephrology 2000;20(3):180-6.
2000: Malyszko J S; Malyszko J; Pawlak K; Pawlak D; Buczko W; Mysliwiec M
Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin.
Nephron 2000;84(4):305-11.
2000: Malyszko J; Zbroch E; Wolczynski S; Mysliwiec M
[Selected parameters of bone metabolism in hemodialyzed and peritoneally dialyzed patients]
Przegla¸d lekarski 2000;57(12):711-3.
2000: Malyszko J; Malyszko J; Mysliwiec M
[Tissue factor and tissue factor pathway inhibitor in peritonitis treated with dialysis]
Przegla¸d lekarski 2000;57(7-8):374-7.
2000: Brzósko S; Mysliwiec M
[HIV nephropathy and other kidney diseases in patients with human immunodeficiency virus infections]
Przegla¸d lekarski 2000;57(3):160-4.
1999: Malyszko J; Zbroch E; Wolczynski S; Malyszko J S; Mysliwiec M
Leptinaemia in patients dialysed with different buffers and dialysis membranes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(10):2527-9.
1999: Malyszko J S; Malyszko J; Mysliwiec M
Tissue factor and tissue factor pathway inhibitor in kidney allograft recipients.
Transplantation proceedings 1999;31(5):2118-20.
1999: Zbroch E; Malyszko J; Wolczynski S; Hryszko T; Mysliwiec M
[Concentration of leptin in patients on hemodialysis and peritoneal dialysis]
Polskie archiwum medycyny wewn?trznej 1999;101(6):503-8.
1999: Malyszko J S; Malyszko J; Mysliwiec M
[Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome]
Polskie archiwum medycyny wewn?trznej 1999;101(4):301-5.
1999: Hryszko T; Malyszko J; Mysliwiec M
[Dysfunction of platelets in uremia]
Przegla¸d lekarski 1999;56(9):599-603.
1999: Brzósko S; Hryszko T; Malyszko J; Mysliwiec M
[Calcium blockers and their their present application]
Przegla¸d lekarski 1999;56(9):592-8.
1999: Azzadin A; Wollny T; Pawlak R; Malyszko J S; Malyszko J; Mysliwiec M; Buczko W
L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
Nephron 1999;83(4):370-1.
1999: Zbroch E; Malyszko J; Mysliwiec M
[New concepts in the pathogenesis of essential hypertension]
Przegla¸d lekarski 1999;56(4):281-5.
1998: Malyszko J S; Malyszko J; Pawlak D; Buczko W; Mysliwiec M
Hemostasis, platelet functions, serotonin and serum lipids during omega-3 fatty acid treatment in patients with glomerulonephritis.
Nephron 1998;80(1):94-6.
1998: Pawlak D; Pawlak K; Chabielska E; Malyszko J; Takada A; Mysliwiec M; Buczko W
A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.
Thrombosis research 1998;90(6):259-70.
1998: Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M
Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
Thrombosis research 1998;90(4):171-80.
1998: Borawski J; Rydzewski A; Azzadin A; Buczko W; Mysliwiec M
Modulation of hematopoiesis by ketanserin in erythropoietin-treated uremic patients: evidence from platelet studies.
Platelets 1998;9(1):31-5.
1998: Naumnik B; Malyszko J; Mysliwiec M
[The role of tissue factor and its inhibitor in hemostasis]
Przegla¸d lekarski 1998;55(2):68-73.
1997: Rydzewski A; Malyszko J; Borawski J; Pawlak D; Azzadin A; Buczko W; Mysliwiec M
Altered circadian rhythm of platelet aggregation in hemodialyzed patients.
Nephron 1997;77(3):365-7.
1997: Rydzewski A; Malyszko J; Borawski J; Pawlak D; Adamcewicz K; Buczko W; Mysliwiec M
[Altered circadian rhythm of platelet aggregation in patients on longterm hemodialysis]
Przegla¸d lekarski 1997;54(3):167-70.
1996: Borawski J; Rydzewski A; Mazerska M; Kalinowski M; Pawlak K; Mysliwiec M
Inverse relationships between haemoglobin and ristocetin-induced platelet aggregation in haemodialysis patients under erythropoietin therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(12):2444-8.
1996: Malyszko J S; Malyszko J; Pawlak K; Mysliwiec M; Takada Y; Takada A
Effects of azathioprine and mizoribine on aggregation of normal and uremic platelets.
Transplantation proceedings 1996;28(6):3488-9.
1996: Poplawski A; Mysliwiec M
[An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia]
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 1996;1(4):246-8.
1996: Malyszko J; Malyszko J S; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Thrombosis research 1996;83(5):351-61.
1996: Pawlak D; Malyszko J; Malyszko J S; Pawlak K; Buczko W; Mysliwiec M
Peripheral serotonergic system in uremia.
Thrombosis research 1996;83(2):189-94.
1996: Mysliwiec J; Azzadin A; Chabielska E; Takada A; Mysliwiec M; Buczko W
The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats.
Thrombosis research 1996;83(2):175-81.
1996: Malyszko J; Pawlak D; Pawlak K; Malyszko J S; Buczko W; Azzudin A; Mysliwiec M
Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
Transplantation proceedings 1996;28(3):1954-7.
1996: Krygicz D; Azzadin A; Pawlak R; Malyszko J S; Pawlak D; Mysliwiec M; Buczko W
Cyclosporine A affects serotonergic mechanisms in uremic rats.
Polish journal of pharmacology 1996;48(3):351-4.
1996: Malyszko J; Malyszko J S; Pawlak D; Pawlak K; Rydzewski A; Mysliwiec M; Buczko W
Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
Polish journal of pharmacology 1996;48(2):191-5.
1996: Pawlak K; Malyszko J S; Malyszko J; Mysliwiec M
Effects of endothelin-1 on aggregation of normal and uremic platelets.
Polish journal of pharmacology 1996;48(2):185-90.
1996: Borawski J; Mazerska M; Rydzewski A; Pawlak K; Rowinski M; Mysliwiec M
Ketanserin: a new perspective in posttransplant erythrocytosis?
Clinical transplantation 1996;10(1 Pt 1):63-6.
1996: Pawlak D; Malyszko J; Mysliwiec M; Takada A; Buczko W
Effect of DV-7028, a novel serotonin 5-HT2 receptor antagonist on the cardiovascular system in rats.
Acta physiologica Hungarica 1996;84(3):325-6.
1996: Pawlak D; Malyszko J; Mysliwiec M; Takada A; Buczko W
Influence of MCI-9042, a novel 5-HT2 receptor blocker on blood vessels of the rat.
Acta physiologica Hungarica 1996;84(3):323-4.
1996: Malyszko J S; Malyszko J; Pawlak K; Mysliwiec M
[Effect of treating glomerulonephritis with omega 3 fatty acids for selected parameters of hemostasis, blood platelet function and lipid metabolism]
Przegla¸d lekarski 1996;53(8):600-3.
1996: Malyszko J S; Malyszko J; Pawlak K; Mysliwiec M
Erythropoietin and uremic platelet aggregation in vivo and in vitro.
International journal of clinical & laboratory research 1996;26(3):199-202.
1996: Borawski J; Mazerska M; Pawlak K; Mysliwiec M
Ketanserin and erythropoiesis in hemodialysis patients with polycystic kidneys.
American journal of nephrology 1996;16(5):451-2.
1996: Azzadin A; Malyszko J; Malyszko J S; Buczko W; Mysliwiec M
Correlation between serotonin concentration and blood pressure in kidney transplant recipients treated with cyclosporine.
Nephron 1996;72(2):336-7.
1995: Malyszko J; Malyszko J; Mazerska M; Mysliwiec M
[Lipid metabolism and fibrinolysis in diabetic nephropathy in the course of diabetes type II]
Polskie archiwum medycyny wewn?trznej 1995;94(4):324-30.
1995: Borawski J; Mazerska M; Pawlak K; Mysliwiec M
Ketanserin lowers erythropoietin concentration in hemodialyzed patients treated with the hormone.
Journal of cardiovascular pharmacology 1995;26(4):621-6.
1995: Malyszko J; Pawlak K; Borawski J; Malyszko J S; Mysliwiec M
Effect of ketanserin on platelet function and bleeding time in uremic patients treated with erythropoietin.
Thrombosis research 1995;78(6):541-6.
1995: Azzadin A; Mysliwiec J; Wollny T; Mysliwiec M; Buczko W
Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats.
Thrombosis research 1995;77(3):217-24.
1995: Malyszko J; Malyszko J S; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
Thrombosis research 1995;77(2):133-43.
1995: Malyszko J S; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
Thrombosis and haemostasis 1995;73(1):164-5.
1995: Malyszko J; Sosnowski S; Mazerska M; Raimer M; Romatowski J; Stasiewicz J; Kemona A; Mysliwiec M
Gastric and pancreatic functions in haemodialyzed patients.
International urology and nephrology 1995;27(4):471-8.
1994: Malyszko J; Malyszko J S; Mysliwiec M
[Fibrinolytic and lipid disturbances in patients with nephrotic syndrome]
Polskie archiwum medycyny wewn?trznej 1994;92(5):394-9.
1994: Rowinski M; Rydzewski A; Malyszko J S; Malyszko J; Mysliwiec M
[Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome]
Przegla¸d lekarski 1994;51(2):77-81.
1994: Borawski J; Mazerska M; Pawlak K; Mysliwiec M
[Ketanserin decreases erythropoietin concentration in hemodialyzed patients on rHuEPO therapy]
Polskie archiwum medycyny wewn?trznej 1994;92 Spec No():14-20.
1993: Malyszko J; Pawlak K; Mazerska M; Malyszko J; Mysliwiec M
[Erythropoietin and fibrinolysis in uremic patients]
Polskie archiwum medycyny wewn?trznej 1993;90(4):267-9.
1993: Malyszko J; Malyszko J; Pietraszek M; Azzadin A; Mysliwiec M; Buczko W
[Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia]
Polskie archiwum medycyny wewn?trznej 1993;90(2):105-11.
1993: Malyszko J; Mazerska M; Malyszko J; Pawlak K; Azzadin A; Mysliwiec M; Buczko W
Serotonergic mechanisms are involved in the hemostatic action of erythropoietin in uremic patients.
International journal of clinical & laboratory research 1993;23(1):42-4.
1992: Malyszko J; Malyszko J S; Azzadin A; Mysliwiec M; Buczko W
DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.
Thrombosis research 1992;68(3):303-8.
1992: Pietraszek M; Azzadin A; Buczko W; Malyszko J; Mysliwiec M
A partial role of serotonin in normalization of the bleeding time by DDAVP in uraemic rats.
Thrombosis and haemostasis 1992;68(5):625.
1992: Mazerska M; Pawlak K; Azzadin A; Malyszko J; Malyszko J; Mysliwiec M; Buczko W
[Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia]
Polskie archiwum medycyny wewn?trznej 1992;88(4):230-7.
1992: Azzadin A; Bialkowska A; Pawlak D; Chabielska E; Mazerska M; Mysliwiec M; Buczko W
Serotonin is involved in some effects of erythropoietin.
Thrombosis research 1992;65(4-5):657-61.
1992: Szewczuk J; Mazerska M; Malyszko J; Kalinowski M; Mysliwiec M
Increase in fibrinolytic activity after erythropoietin therapy.
Thrombosis and haemostasis 1992;67(2):284.
1992: Pietraszek M; Malyszko J; Azzadin A; Malyszko J; Buczko W; Mysliwiec M
Serotonin and hypertension in uraemia: a possible link?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7(9):980-1.
1992: Azzadin A; Bialkowska A; Buczko W; Malyszko J; Kalinowski M; Mysliwiec M
Serotonergic mechanism of erythropoietin-induced hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7(8):882-3.
1992: Malyszko J; Mysliwiec M
[Antiplatelet drugs]
Przegla¸d lekarski 1992;49(8):271-3.
1992: Mysliwiec M
[Complications of nephrotic syndrome (NS) and the possibility of their treatment]
Przegla¸d lekarski 1992;49(1-2):23-5.
1991: Mysliwiec M; Poplawski A; Soszka J
[Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation]
Polski tygodnik lekarski (Warsaw, Poland : 1960) 1991;46(4-5):76-8.
1990: Poplawski A; Mysliwiec M; Soszka J
[Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]]
Polski tygodnik lekarski (Warsaw, Poland : 1960) 1990;45(40-41):810-3.
1990: Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
Folia haematologica (Leipzig, Germany : 1928) 1990;117(2):319-24.
1989: Poplawski A; Mysliwiec M; Soszka J
[Value of intermediate compounds in ultrafiltration depending on the type of dialysis and their effect on fibrinolytic activity]
Polski tygodnik lekarski (Warsaw, Poland : 1960) 1989;44(36-39):827-9.
1989: Malyszko J; Pietraszek M H; Azzadin A; Buczko W; Mysliwiec M
Desmopressin induces decrease in platelet serotonin content in uremia.
Thrombosis and haemostasis 1989;61(3):537.
1988: Mysliwiec M; Soszka J
[Blood platelet function in patients with chronic renal failure]
Polskie archiwum medycyny wewn?trznej 1988;80(4):189-95.
1986: Rydzewski A; Rowinski M; Mysliwiec M
Desmopressin induces decrease in platelet count in uremia.
Thrombosis and haemostasis 1986;55(3):436.
1986: Poplawski A; Mysliwiec M; Soszka J; Rydzewski A; Rowinski M
[Effect of heparin and venous stasis on the fibrinolytic activity of the blood]
Polski tygodnik lekarski (Warsaw, Poland : 1960) 1986;41(22):707-9.
1986: Mysliwiec M; Kuzmicka N; Poplawski A; Soszka J
[Early thrombocytopenia after administration of heparin in patients with chronic renal failure]
Polski tygodnik lekarski (Warsaw, Poland : 1960) 1986;41(12):363-6.
1986: Mysliwiec M; Tomasiak M; Pytel B; Soszka J
[Serotonin levels in the blood of patients with terminal renal failure]
Polski tygodnik lekarski (Warsaw, Poland : 1960) 1986;41(2):35-7.
1986: Rydzewski A; Rowinski M; Mysliwiec M
Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
Folia haematologica (Leipzig, Germany : 1928) 1986;113(6):823-30.
1986: Rydzewski A; Mysliwiec M; Soszka J
Concentration of three thrombin inhibitors in the nephrotic syndrome in adults.
Nephron 1986;42(3):200-3.
1985: Mysliwiec M; Bodzenta A; Rydzewski A; Soszka J
Plasma thromboxane B2 in haemodialysed patients.
Folia haematologica (Leipzig, Germany : 1928) 1985;112(3):442-6.
1983: Rydzewski A; Soszka J; Mysliwiec M
[Antithrombin III activity during hemodialysis]
Polskie archiwum medycyny wewn?trznej 1983;69(2):123-8.
1983: Soszka J; Rydzewski A; Mysliwiec M
Normal response to uraemic platelets to thromboxane A2 agonist.
Nephron 1983;35(4):267-8.

Sign-in to see more